Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Low Risk High Growth Stocks to Buy. Amid carrying on new studies, the company has agreed to acquire Verve Therapeutics. Eli Lilly and Company ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

Novo Nordisk A/S (NYSE:NVO) is one of the stocks that Jim Cramer shed light on. A caller asked about the stock’s status, and ...

Eli Lilly is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit ...

Novo Nordisk faces challenges in the competitive GLP-1 market, but its strong brand and R&D create opportunities for long-term investors to capitalize now.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

Eli Lilly closed at $1.87, ranked 34th in trading volume on July 22, 2025. BMO Capital remains bullish, reiterating a buy ...

Eli Lilly & Co. closed 20.16% below its 52-week high of $972.53, which the company achieved on August 22nd.

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

With Richard Ayoade with David Letterman, Robert Downey Jr., Kamilah Forbes, Scott Galloway, Tom Hanks, Becky Kennedy, and ...

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side effects.

The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...